Lloyd Price

APRIL 22, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Pharma giants acquiring AI drug discovery firms: Pharmaceutical companies are increasingly looking to AI to streamline drug development, leading to potential acquisitions. Email lloyd@nelsonadvisors.co.uk

healthcare technology 60

healthcare technology Leadership Drug Development Digital Health 60

Lloyd Price

FEBRUARY 18, 2024

AI and machine learning: Companies with advanced AI solutions for tasks like drug discovery, clinical trial optimisation, and personalised medicine can be attractive targets. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 64

Pharmaceuticals healthcare technology Digital Health Remote care 64

Lloyd Price

MAY 6, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. AI can optimise clinical trial design and patient selection, leading to faster and more efficient drug development processes. Email lloyd@nelsonadvisors.co.uk Email lloyd@nelsonadvisors.co.uk Visit [link]

healthcare technology 70

healthcare technology Leadership Drug Development Digital Health 70

Lloyd Price

FEBRUARY 18, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Digital Health Global

MARCH 16, 2023

We are excited to support Seamless Therapeutics in its pursuit of taking a leadership position in the rapidly evolving gene editing arena,” added Karl Nägler, PhD, Managing Partner at Wellington Partners. “At billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development.

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Healthcare IT Today

JANUARY 23, 2024

Drug population and drug protocol fit account for nearly 75% of these failures. By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drug development. Petra Jantzer, Ph.D.,

Drug Development 93

Drug Development Pharmaceuticals Life Science BioTech 93

Lloyd Price

FEBRUARY 2, 2024

Enhanced research efficiency: Researchers can gain faster access to anonymized patient data with patient consent through SSI, accelerating research efforts and drug development. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Health Data 64

Health Data Interoperability healthcare technology Leadership 64

Lloyd Price

FEBRUARY 22, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pain management 56

Pain management Mental health Telehealth healthcare technology 56

Lloyd Price

NOVEMBER 21, 2018

In an interview with the Wall Street Journal, Narasimhan pointed to some of the investments the company has made into the cutting-edge areas of drug development, such as gene therapy and radiopharmaceuticals.

Drug Development 43

Drug Development Leadership 43

Lloyd Price

APRIL 29, 2024

Boost research and innovation: Researchers will have a secure platform to access and analyse large datasets for medical research, leading to advancements in disease prevention, treatment, and drug development. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Health Data 64

Health Data healthcare technology Digital Health Leadership 64

Healthcare IT Today

FEBRUARY 28, 2020

New healthcare AI and Machine Learning research conducted by Healthcare IT Today suggests that many industry leaders are serious about adopting healthcare AI and machine learning tools and what’s more, that these technologies are being used as part of mission-critical efforts rather than one-off pilot tests.

Health IT 86

Health IT Healthcare IT Drug Development Patient Experience 86

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Healthcare IT Today

MAY 5, 2023

Technology continues to play a large role in healthcare, expediting and reducing the costs associated with the drug development process. The implementation of AI has been instrumental in significantly cutting down the drug development timeline and creating viable drug targets in a more timely and cost-efficient manner.

Drug Development 90

Drug Development Primary Care Remote care Patient Experience 90

Healthcare IT Today

JANUARY 17, 2024

Precision medicine will continue to evolve in 2024: In disease areas like oncology, we will start to see AI playing a larger role in target discovery and biomarker or patient subpopulation identification, the cornerstones to early precision drug development.

Health IT 109

Health IT Mental health Interoperability Patient Experience 109